Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Freidrich Anselmo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinics in Dermatology|November 17, 2021
Deleterious side effects of nutritional supplementsFreidrich Anselmo, Marcia S Driscoll
Experimental and Molecular Pathology|July 21, 2018
Phosphorylated SIRT1 as a biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosisJonathan Ciriello, Alexandru Tatomir, Daniel Hewes, et al.
Immunologic Research|June 29, 2019
RGC-32 and diseases: the first 20 yearsSonia I Vlaicu, Alexandru Tatomir, Freidrich Anselmo, et al.
Clinical Immunology (Orlando, Fla.)|November 8, 2019
JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic responseFreidrich Anselmo, Alexandru Tatomir, Dallas Boodhoo, et al.
Immunologic Research|November 9, 2017
The complement system as a biomarker of disease activity and response to treatment in multiple sclerosisAlexandru Tatomir, Anamaria Talpos-Caia, Freidrich Anselmo, et al.
Frontiers in Immunology|April 25, 2020
Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in OligodendrocytesAlexandru Tatomir, Gautam Rao, Dallas Boodhoo, et al.
Frontiers in Immunology|July 12, 2024
Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosisAlexandru Tatomir, Freidrich Anselmo, Dallas Boodhoo, et al.
Immunologic Research|July 15, 2018
RGC-32 regulates reactive astrocytosis and extracellular matrix deposition in experimental autoimmune encephalomyelitisAlexandru Tatomir, Cosmin A Tegla, Alvaro Martin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinics in Dermatology|November 17, 2021
Deleterious side effects of nutritional supplementsFreidrich Anselmo, Marcia S Driscoll
Experimental and Molecular Pathology|July 21, 2018
Phosphorylated SIRT1 as a biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosisJonathan Ciriello, Alexandru Tatomir, Daniel Hewes, et al.
Immunologic Research|June 29, 2019
RGC-32 and diseases: the first 20 yearsSonia I Vlaicu, Alexandru Tatomir, Freidrich Anselmo, et al.
Clinical Immunology (Orlando, Fla.)|November 8, 2019
JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic responseFreidrich Anselmo, Alexandru Tatomir, Dallas Boodhoo, et al.
Immunologic Research|November 9, 2017
The complement system as a biomarker of disease activity and response to treatment in multiple sclerosisAlexandru Tatomir, Anamaria Talpos-Caia, Freidrich Anselmo, et al.
Frontiers in Immunology|April 25, 2020
Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in OligodendrocytesAlexandru Tatomir, Gautam Rao, Dallas Boodhoo, et al.
Frontiers in Immunology|July 12, 2024
Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosisAlexandru Tatomir, Freidrich Anselmo, Dallas Boodhoo, et al.
Immunologic Research|July 15, 2018
RGC-32 regulates reactive astrocytosis and extracellular matrix deposition in experimental autoimmune encephalomyelitisAlexandru Tatomir, Cosmin A Tegla, Alvaro Martin, et al.
Pageof 1